Solara Active Pharma Sciences Limited
NSE:SOLARA.NS
651.9 (INR) • At close July 30, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||
| Nettowinst
| 5.4 | -4,884.2 | -448.1 | -911 | 2,215 | 1,149.1 | 577.76 | 1.97 | -0.396 |
| Afschrijvingen & Amortisatie
| 992.5 | 1,033.3 | 1,112.1 | 1,123.2 | 1,086.6 | 941.6 | 837.04 | 367.09 | 0 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 192.7 | -31.9 | -347.4 | -186.7 | -202.71 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 26.8 | 6 | 0.5 | -13.1 | 51.4 | 56 | 23.89 | 0 | 0 |
| Verandering in Werkkapitaal
| 624.5 | 1,906.3 | 7.2 | -3,137.9 | -2,058.4 | -164.5 | -317.96 | -108.39 | 0 |
| Vorderingen
| 198.1 | 1,781.7 | -528 | -145.5 | -2,573.7 | 678 | -553.4 | -391.82 | 0 |
| Voorraden
| 418 | 130.8 | 173.2 | -2,805.8 | -152.4 | -657.9 | -307.9 | -269.39 | 0 |
| Crediteuren
| -594.3 | 73 | 389 | -238.8 | 966.7 | -280.5 | -509.8 | 444.18 | 0 |
| Overig Werkkapitaal
| 8.4 | -79.2 | -27 | 52.2 | -299 | 95.9 | 1,053.14 | 161 | 0 |
| Overige Niet-Contante Posten
| 479 | 3,027.3 | 698.1 | 550.4 | 607.4 | 646.7 | 680.61 | 231.56 | 0.396 |
| Kasstroom uit Operationele Activiteiten
| 2,128.2 | 1,088.7 | 1,562.5 | -2,420.3 | 1,554.6 | 2,442.2 | 1,598.63 | 492.23 | 0 |
| Investeringsactiviteiten: | |||||||||
| Investeringen in Materiële Vaste Activa
| -399.4 | -410.6 | -1,113.1 | -2,086.2 | -1,744.8 | -2,688.7 | -525.43 | -347.36 | 0 |
| Netto Overnames
| 3.8 | 0 | -12.8 | 1.3 | -1 | -550.1 | -638.57 | -509 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | -12.8 | 0 | 0 | -500 | -4 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 9.6 | 0 | 12.8 | 0 | 0 | 91.8 | 4 | 0 | 0 |
| Overige Investeringsactiviteiten
| 10.2 | 375.5 | 314.5 | -343.6 | 682.8 | 58.9 | 71.77 | 1.68 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -368.3 | -35.1 | -811.4 | -2,428.5 | -1,063 | -3,588.1 | -1,092.23 | -854.68 | 0 |
| Financieringsactiviteiten: | |||||||||
| Schuldaflossingen
| -2,213.8 | -1,144.7 | -647.5 | 1,661.8 | -1,001.5 | 1,635.6 | -880.7 | 528.31 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 29 | 2,981.6 | 297.6 | 1,480 | 0.1 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | -107.8 | -197.3 | -156.2 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -1,424 | 88.2 | -480.1 | 1,752.7 | -857.9 | -807.2 | -891.1 | 148.96 | 1.2 |
| Kasstroom uit Financieringsactiviteiten
| -1,804.8 | -1,056.5 | -1,127.6 | 3,335.7 | 924.9 | 949.1 | -233.84 | 677.37 | 1.2 |
| Overige Informatie: | |||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 25.13 | 0 | 0 |
| Netto Kasstroomverandering
| -44.9 | -2.9 | -376.5 | -1,513.1 | 1,416.5 | -196.8 | 297.69 | 314.92 | 1.2 |
| Kaspositie aan het Einde van de Periode
| 39.5 | 84.4 | 87.3 | 463.8 | 1,976.9 | 560.4 | 757.21 | 459.52 | 1.2 |